BBIO R&D Expense Growth

Bridgebio Pharma Inc · R&D Expense Growth

BBIO logo

BBIO R&D Expense Growth

Latest reported-5.71%
BBIO FY R&D Growth (YoY) (0.00% → -5.71%)
High-resolution chart · PNG

BBIO r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
-5.7112%
11.1364%
14.0812%
-11.4322%
33.8164%
60.5391%
49.884%
358.4141%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.